Merck & Co Inc
NYSE: MRK
$98.05
-$1.47 (-1.5%)
Closing Price on December 20, 2024
MRK Articles
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple the position as the best performing Dow stock of 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Published:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.
Published:
Last Updated:
After an absence of more than a year, Apple is once more the top-performing Dow stock for the year to date. Considering the company's market cap of $1.05 trillion, that's quite an accomplishment.
Published:
Last Updated:
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, Exxon, Verizon and other Dow industrials scheduled to report their quarterly results this week.
Published:
Last Updated:
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Intel, Walgreens, Johnson & Johnson, and Merck led the Dow higher Thursday.
Published:
Last Updated:
Merck shares retreated to start off the week despite the announcement of good news from the FDA.
Published:
Last Updated: